How to buy MediciNova stock

MediciNova, Inc is a biotechnology business based in the US. MediciNova shares (MNOV) are listed on the NASDAQ and all prices are listed in US Dollars. MediciNova employs 9 staff and has a market cap (total outstanding shares value) of 0.00.

MediciNova share price

Use our graph to track the performance of MNOV stocks over time.

MediciNova shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$4.28 - $7.45
50-day moving average	$5.28
200-day moving average	$5.66
Wall St. target price	$17.63
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.37

Buy MediciNova shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy MediciNova stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of MediciNova, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MediciNova financials

Gross profit TTM	$0
Return on assets TTM	-11.46%
Return on equity TTM	-18.95%
Profit margin	0%
Book value	$1.58
Market capitalisation	$222.4 million

TTM: trailing 12 months

Shorting MediciNova shares

There are currently 3.1 million MediciNova shares held short by investors – that's known as MediciNova's "short interest". This figure is 2.1% down from 3.1 million last month.

There are a few different ways that this level of interest in shorting MediciNova shares can be evaluated.

MediciNova's "short interest ratio" (SIR)

MediciNova's "short interest ratio" (SIR) is the quantity of MediciNova shares currently shorted divided by the average quantity of MediciNova shares traded daily (recently around 2.1 million). MediciNova's SIR currently stands at 1.47. In other words for every 100,000 MediciNova shares traded daily on the market, roughly 1470 shares are currently held short.

However MediciNova's short interest can also be evaluated against the total number of MediciNova shares, or, against the total number of tradable MediciNova shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MediciNova's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 MediciNova shares in existence, roughly 60 shares are currently held short) or 0.0663% of the tradable shares (for every 100,000 tradable MediciNova shares, roughly 66 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MediciNova.

Find out more about how you can short MediciNova stock.

MediciNova share dividends

We're not expecting MediciNova to pay a dividend over the next 12 months.

Have MediciNova's shares ever split?

MediciNova's shares were split on a 1:10 basis on 30 October 2006. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MediciNova shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for MediciNova shares which in turn could have impacted MediciNova's share price.

MediciNova share price volatility

Over the last 12 months, MediciNova's shares have ranged in value from as little as $4.28 up to $7.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MediciNova's is 1.4523. This would suggest that MediciNova's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

MediciNova overview

MediciNova, Inc. , a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has a collaboration agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.

Frequently asked questions

• What percentage of MediciNova is owned by insiders or institutions?

  Currently 7.301% of MediciNova shares are held by insiders and 34.254% by institutions.

• How many people work for MediciNova?

  Latest data suggests 9 work at MediciNova.

• When does the fiscal year end for MediciNova?

  MediciNova's fiscal year ends in December.

• Where is MediciNova based?

  MediciNova's address is: 4275 Executive Square, La Jolla, CA, United States, 92037

• What is MediciNova's ISIN number?

  MediciNova's international securities identification number is: US58468P2065

• What is MediciNova's CUSIP number?

  MediciNova's Committee on Uniform Securities Identification Procedures number is: 58468P206